All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Hepatitis B Virus Infection-15968333

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	15968333	G119E	S	S	Hepatitis B Virus Infection		View
2	15968333	V17F	PreC	C	Hepatitis B Virus Infection		View
3	15968333	I110M	S	S	Hepatitis B Virus Infection		View
4	15968333	R169P	S	S	Hepatitis B Virus Infection		View
5	15968333	M133T	S	S	Hepatitis B Virus Infection		View
6	15968333	C1766T	C	C	Hepatitis B Virus Infection	G	View
7	15968333	T1768A	C	C	Hepatitis B Virus Infection		View
8	15968333	A1762T	Core Promoter		Hepatitis B Virus Infection	G	View
9	15968333	G1764A	Core Promoter		Hepatitis B Virus Infection	G	View
10	15968333	G510A	S	S	Hepatitis B Virus Infection		View
11	15968333	G660C	S	S	Hepatitis B Virus Infection		View
12	15968333	S466A	P	P	Hepatitis B Virus Infection		View
13	15968333	T484G	S	S	Hepatitis B Virus Infection		View
14	15968333	T552C	S	S	Hepatitis B Virus Infection		View
15	15968333	G1896A	PreC	C	Hepatitis B Virus Infection		View
16	15968333	E77Q	C	C	Hepatitis B Virus Infection	G	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.